To determine if osteoblast-specific deletion of GSK3β ameliorates vascular calcification in diabetes mellitus, we treated mice at 34 weeks of age with tamoxifen (75 mg/kg, daily) for 5 days to delete GSK3β in osteoblast-like cells as previously described [25]. This evidence concerns the gene GSK3B and diabetes mellitus.